EUVIMEDEUVIMED entdecken
Crossref

Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer

Hitoshi Hirakawa, Taro Ikegami, Hidetoshi Kinjyo, Yoshikazu Hayashi, Shinya Agena, Teruyuki Higa, Shunsuke Kondo, Masatomo Toyama, Hiroyuki Maeda, Mikio Suzuki

Anticancer Research · 2024

DOI: 10.21873/anticanres.17218 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Hitoshi Hirakawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan aoi23@med.u-ryukyu.a…. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Head and Neck Neoplasms, Immunotherapy, Feasibility Studies. Die Arbeit wurde bisher 16-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsHead and Neck NeoplasmsImmunotherapyFeasibility StudiesHumansMaleAgedMiddle AgedFemaleSquamous Cell Carcinoma of Head and NeckCombined Modality TherapyNeoplasm Recurrence, LocalPhototherapyTreatment OutcomeAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

JapaneseNear-infrared photoimmunotherapyhead and neck cancerimmune checkpoint inhibitor

Substanzen

Immune Checkpoint InhibitorspembrolizumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan aoi23@med.u-ryukyu.ac.jp.
  • Department of Otorhinolaryngology, Head and Neck Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.

Zitieren

APA

Hirakawa, H., Ikegami, T., Kinjyo, H., Hayashi, Y., Agena, S., Higa, T., Kondo, S., Toyama, M., Maeda, H., & Suzuki, M. (2024). Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17218

Vancouver

Hirakawa H, Ikegami T, Kinjyo H, Hayashi Y, Agena S, Higa T, et al. Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.17218

BibTeX
@article{Hirakawa2024,
  author = {Hirakawa, Hitoshi and Ikegami, Taro and Kinjyo, Hidetoshi and Hayashi, Yoshikazu and Agena, Shinya and Higa, Teruyuki and Kondo, Shunsuke and Toyama, Masatomo and Maeda, Hiroyuki and Suzuki, Mikio},
  title = {Feasibility of Near-infrared Photoimmunotherapy Combined With Immune Checkpoint Inhibitor Therapy in Unresectable Head and Neck Cancer},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17218}
}
Kostenlos starten →